MarketInOut Stock Screener Log In | Sign Up
 

Danaher Corp

NYSE • Healthcare • Diagnostics & Research • Quote as of 06/05/2026
Danaher Corp stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNYSE
Market Capitalization132,098 mln
Float631 mln
Earnings Date07/28/2026

EPS

5.15
Stretched

P / E

35.79
Overvalued

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.58
Likely reliable

1-Year Forecast

244
Strong upside

Relative Strength

92 / 100
Top performer

Business Description

Danaher Corporation is a Washington, D.C.-based company that develops and sells a broad range of tools, instruments, and services used in medical research, disease diagnosis, and industrial applications across the United States and global markets. Its work spans helping scientists develop new medicines, equipping laboratories with advanced measurement and analysis technology, and supporting hospitals and clinics with the diagnostic tools they need to identify illness and guide patient care. Founded in 1969 and operating under the Danaher name since 1984, the company serves customers worldwide through a portfolio of well-established brands.

Key Fundamentals

EPS5.15
P/E35.79
ROE7.10
RPS34.72
ROIC5.55
ROA4.52
Interest Cover18.59
EBITDA, mln7,078
EV / EBITDA19.19
EV / EBIT29.56
Revenue, mln24,778
EV / Revenue5.48

Financial Strength

Altman Z-Score3.77
Piotroski F-Score 7 / 9
Beneish M-Score-2.58
Price to Intrinsic Value1.34
1-Year Target Price244
Shiller PE Ratio28.76
Short Ratio1.55
Short % of Float1.33

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.89% 81 / 100   
1 Month 5.36% 90 / 100   
2 Months -12.32% 15 / 100   
6 Months -19.05% 10 / 100   
1 Year -3.89% 17 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us